Acacia Research Investor

Acacia Research Corporation (NASDAQ: ACTG) is the industry leader in patent licensing. By partnering with patent owners, Acacia applies its deep legal and technology expertise to patent assets to unlock financial value. An intermediary in the patent market, Acacia facilitates efficiency and delivers monetary rewards to the patent owner. With this strategy, Acacia has generated over $1,200,000,000 revenue to date, and has returned more than $694,000,000 to our patent partners. Acacia Research Corporation was founded in 1993 by Bruce Stewart. Mr. Stewart, with strong ties to the California Institute of Technology, was a serial inventor and entrepreneur who valued innovation. Mr. Stewart’s vision for Acacia combined investment capital, ideas and bright people, allowing their emerging inventions to flourish. From that origin, Acacia and our patent partners have signed more than 1200 licensing agreements with many of the world’s largest companies. Consistent with its innovation heritage, Acacia has returned more than $694,000,000 to our patent partners. The Acacia team is un-paralleled in its ability to identify, secure, analyze and monetize intellectual property in a rapidly developing secondary market for patent assets.

Invests into

Technology: N/A
Industry: Precision Medicine
Headquarters: Newport Beach, California, United States
Founded Date: 1993
Employees Number: 101-250
Funding Status: IPO
Investor Type: undisclosed
Investment Stage: Undisclosed
Number Of Exits: undisclosed

Visit Website
Register and Claim Ownership